Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease

Movement Disorders

Volumn 31, Issue 7, 2016, Pages 1062-1066

  Breen, David P ^a   Nombela, Cristina ^a,h   Vuono, Romina ^a   Jones, P Simon ^b   Fisher, Kate ^a,i   Burn, David J ^c   Brooks, David J ^d,e   Reddy, Akhilesh B ^b   Rowe, James B ^b,f,g   Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^h TECHNICAL UNIVERSITY OF CARTAGENA   (Spain)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

circadian; hypothalamus; melatonin; Parkinson's; suprachiasmatic nucleus

Indexed keywords

LEVODOPA; MELATONIN;

AGED; ARTICLE; BLOOD SAMPLING; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAY MATTER; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMIC GRAY MATTER VOLUME; HYPOTHALAMIC TISSUE; HYPOTHALAMIC VOLUME LOSS; MALE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 84977577111     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26592     Document Type: Article

References (10)

1. Breen DP, Vuono R, Nawarathna U, et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol 2014;71:589-595.
2. Videnovic A, Noble C, Reid KJ, et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 2014;71:463-466.
3. Kakkiolia E, Silajdzic E, Nambron R, et al. Plasma melatonin is reduced in Huntington's disease. Mov Disord 2014;29:1511-1515.
4. Mishima K, Tozawa T, Satoh K, et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry 1999;45:417-421.
5. Nombela C, Rowe JB, Winder-Rhodes SE, et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain 2014;137:2743-2758.
6. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
7. Videnovic A, Lazar AS, Barker RA, et al. ‘The clocks that time us’—circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 2014;10:683-693.
8. Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol 1978;3:129-133.
9. Politis M, Piccini P, Pavese N, et al. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp Neurol 2008;214:112-116.
10. Kudo T, Loh DH, Truong D, et al. Circadian dysfunction in a mouse model of Parkinson's disease. Exp Neurol 2011;232:66-75.